WinRevair’s Phase 3 HYPERION trial was stopped early for efficacy, with positive top-line results announced in the month ...

Adjusted EBITDA (Q4): Adjusted EBITDA loss of $316,000 for Q4 FY2025, substantially narrowed from a $1.7 million adjusted ...

Q2 2025 Earnings Conference Call August 4, 2025 1:30 PM ETCompany ParticipantsDaniel Patrick Penberthy - President ...

Good morning, and welcome to the Icahn Enterprises L.P. Second Quarter 2025 Earnings Call with Andrew Teno, President and CEO and and Ted Papapostolou, Chief Financial Officer; and Robert Flint, Chief ...

Q2 2025 Earnings Call Transcript July 31, 2025 Grab Holdings Limited reports earnings inline with expectations. Reported EPS ...